NYSE - Delayed Quote USD
Organon & Co. (OGN)
12.12
+0.63
+(5.48%)
At close: April 24 at 4:00:02 PM EDT
12.13
+0.01
+(0.08%)
After hours: April 24 at 7:47:19 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 559.75k | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| WALSH MATTHEW M Chief Financial Officer | -- | Direct | -- | Mar 31, 2025 |
| ARJONA FERREIRA JUAN CAMILO Officer | -- | Direct | -- | Mar 31, 2025 |
| KARP DANIEL Officer | -- | Direct | -- | Mar 31, 2025 |
| MORRISSEY JOSEPH T JR Officer | -- | Direct | -- | Mar 31, 2025 |
| DIMARCO KATHRYN Officer | -- | Direct | -- | Mar 31, 2025 |
| STAHLER RACHEL A Chief Technology Officer | -- | Direct | -- | Mar 31, 2025 |
| ALI KEVIN Chief Executive Officer | -- | Direct | -- | Mar 31, 2025 |
| FALCIONE AARON Officer | -- | Direct | -- | Mar 31, 2025 |
| NISITA VITTORIO Officer | -- | Direct | -- | Mar 31, 2025 |
| WEAVER KIRKE General Counsel | -- | Direct | -- | Mar 31, 2025 |
| NISITA VITTORIO Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| WALSH MATTHEW M Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| STAHLER RACHEL A Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| ALI KEVIN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| MORRISSEY JOSEPH T JR Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| FALCIONE AARON Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 20, 2025 |
| ARJONA FERREIRA JUAN CAMILO Officer | -- | Direct | -- | Nov 7, 2024 |
| WALSH MATTHEW M Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| STAHLER RACHEL A Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| ALI KEVIN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| FIEDLER SUSANNE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| MORRISSEY JOSEPH T JR Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| DIMARCO KATHRYN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| FALCIONE AARON Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| NISITA VITTORIO Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 3, 2024 |
| ARJONA FERREIRA JUAN CAMILO Officer | -- | Direct | -- | Aug 9, 2024 |
| WALSH MATTHEW M Chief Financial Officer | -- | Direct | -- | May 3, 2024 |
| MORRISSEY JOSEPH T JR Officer | -- | Direct | -- | May 3, 2024 |
| DIMARCO KATHRYN Officer | -- | Direct | -- | May 3, 2024 |
| STAHLER RACHEL A Chief Technology Officer | -- | Direct | -- | May 3, 2024 |
| ALI KEVIN Chief Executive Officer | -- | Direct | -- | May 3, 2024 |
| FIEDLER SUSANNE Officer | -- | Direct | -- | May 3, 2024 |
| FALCIONE AARON Officer | -- | Direct | -- | May 3, 2024 |
| NISITA VITTORIO Officer | -- | Direct | -- | May 3, 2024 |
| WEAVER KIRKE General Counsel | -- | Direct | -- | May 3, 2024 |
| STAHLER RACHEL A Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2024 |
| WALSH MATTHEW M Chief Financial Officer | -- | Direct | -- | Mar 28, 2024 |
| MORRISSEY JOSEPH T JR Officer | -- | Direct | -- | Mar 28, 2024 |
| DIMARCO KATHRYN Officer | -- | Direct | -- | Mar 28, 2024 |
| STAHLER RACHEL A Chief Technology Officer | Conversion of Exercise of derivative security at price 18.80 per share. | Direct | 67,266 | Mar 28, 2024 |
| ALI KEVIN Chief Executive Officer | -- | Direct | -- | Mar 28, 2024 |
| FIEDLER SUSANNE Officer | -- | Direct | -- | Mar 28, 2024 |
| FALCIONE AARON Officer | -- | Direct | -- | Mar 28, 2024 |
| NISITA VITTORIO Officer | -- | Direct | -- | Mar 28, 2024 |
| WEAVER KIRKE General Counsel | -- | Direct | -- | Mar 28, 2024 |
| WALSH MATTHEW M Chief Financial Officer | -- | Direct | -- | Feb 28, 2024 |
| MORRISSEY JOSEPH T JR Officer | -- | Direct | -- | Feb 28, 2024 |
| DIMARCO KATHRYN Officer | -- | Direct | -- | Feb 28, 2024 |
| STAHLER RACHEL A Chief Technology Officer | -- | Direct | -- | Feb 28, 2024 |
| ALI KEVIN Chief Executive Officer | -- | Direct | -- | Feb 28, 2024 |
Related Tickers
MRK Merck & Co., Inc.
79.84
+1.40%
BMY Bristol-Myers Squibb Company
48.69
+0.33%
GSK GSK plc
37.50
+1.27%
SNY Sanofi
53.54
+0.98%
AMGN Amgen Inc.
279.84
+0.70%
PFE Pfizer Inc.
22.78
+1.74%
GILD Gilead Sciences, Inc.
106.15
-0.22%
BIIB Biogen Inc.
119.51
+1.13%
NVS Novartis AG
111.17
+0.94%
AZN AstraZeneca PLC
69.55
+1.52%